作者
Barbara H Braffett, Rose A Gubitosi-Klug, James W Albers, Eva L Feldman, Catherine L Martin, Neil H White, Trevor J Orchard, Maria Lopes-Virella, John M Lachin, Rodica Pop-Busui, DCCT/EDIC Research Group
发表日期
2020/5/1
期刊
Diabetes
卷号
69
期号
5
页码范围
1000-1010
出版商
American Diabetes Association
简介
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study demonstrated that intensive glucose control reduced the risk of developing diabetic peripheral neuropathy (DPN) and cardiovascular autonomic neuropathy (CAN). We evaluated multiple risk factors and phenotypes associated with DPN and CAN in this large, well-characterized cohort of participants with type 1 diabetes, followed for >23 years. DPN was defined by symptoms, signs, and nerve conduction study abnormalities in ≥2 nerves; CAN was assessed using standardized cardiovascular reflex tests. Generalized estimating equation models assessed the association of DPN and CAN with individual risk factors measured repeatedly. During DCCT/EDIC, 33% of participants developed DPN and 44% CAN. Higher mean HbA1c was the most significant risk factor for DPN, followed by older …
引用总数